OFFICIAL PUBLICATION OF

by its subsidiary APPco

Australia ‘not yet COVID-stable’: review

Sheshtyn Paola 28/09/2022

Availability of vaccines and treatments will continue to play a key role in 2023 and 2024 due to uncertainty over future COVID variants, independent report finds A need to mitigate the effects of COVID-19 is likely to remain going forward, according to a new independent review commissioned by Minister for Health Mark Butler. Professor Jane

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Australia ‘not yet COVID-stable’: review

Previous Flourish in pharmacy: practical pathways to better teamwork

Next New offerings from SHPA

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Flourish in pharmacy: practical pathways to better teamwork

Next New offerings from SHPA

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.